Evidence map›Paper›PMID 31107302›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients.

Raha M Dastgheyb, Ned Sacktor, Donald Franklin, Scott Letendre, Thomas Marcotte, Robert Heaton, Igor Grant, Justin C McArthur, Leah H Rubin, Norman J Haughey

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genetic Variations in EIF2AK3 are Associated with Neurocognitive Impairment in People Living with HIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  9. Article
  10. Article
  11. Cognitive Phenotypes of HIV Defined Using a Novel Data-driven Approach.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Associations between Antiretrovirals and Cognitive Function in Women with HIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Article
  18. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Raha M DastgheybDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Ned SacktorDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Donald FranklinHIV Neurobehavioral Research Program, Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA.
Scott LetendreHIV Neurobehavioral Research Program, Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA.
Thomas MarcotteHIV Neurobehavioral Research Program, Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA.
Robert HeatonHIV Neurobehavioral Research Program, Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA.
Igor GrantHIV Neurobehavioral Research Program, Department of Psychiatry, School of Medicine, University of California, San Diego, La Jolla, CA.
Justin C McArthurDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Leah H RubinDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Norman J HaugheyDepartment of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Barbara Stauch Slusher · 2006 to 2026
$33.2M
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER)N01MH22005 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2007 to 2009
$12.0M
Age related determinants of HAND: A 12 year follow-up of CHARTER participantsR01MH107345 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEATON, ROBERT KERNACHAN, LETENDRE, SCOTT L · 2015 to 2021
$7.9M
Surrogate Marker CoreP01MH105280 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SACKTOR, NED C · 2015 to 2019
$6.5M
Mechanisms of Neuroinflammation in HANDR01MH077542 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2007 to 2016
$3.4M
Translational Research in Neuro-AIDS and Mental HealthR25MH080661 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MCARTHUR, JUSTIN CHARLES. · 2007 to 2019
$2.9M
Exosomes:From biogenesis and secretion to the early pathogenesis of Alzheimer's diseaseR01AG057420 · NIA · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2017 to 2021
$2.0M
Altered Amyloid Processing HIVR01MH096636 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2013 to 2017
$2.0M
Dysregualtion of gliotransmission in models of neuroHIVR01MH110246 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2016 to 2020
$2.0M
Oxidative Stress Markers and HIV DementiaR01MH071150 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SACKTOR, NED C · 2005 to 2009
$2.0M
Interaction of Alcohol with HIV-ProteinR01AA017408 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2007 to 2011
$1.9M
NIAAA NIH HHS R01 AA017408NIA NIH HHS R01 AG057420NIA NIH HHS R21 AG034849NIMH NIH HHS HHSN271201000030CNIMH NIH HHS HHSN271201000036CNIMH NIH HHS N01 MH022005NIMH NIH HHS N01MH22005NIMH NIH HHS P01 MH105280NIMH NIH HHS P30 MH062512NIMH NIH HHS P30 MH075673NIMH NIH HHS R01 MH071150NIMH NIH HHS R01 MH077542NIMH NIH HHS R01 MH096636NIMH NIH HHS R01 MH107345NIMH NIH HHS R01 MH110246NIMH NIH HHS R25 MH080661
6 · The paper itself

Abstract

objectiveThe presentation of cognitive impairments in HIV-infected individuals has transformed since the introduction of antiretroviral therapies. Although the overall prevalence of cognitive impairments has not changed considerably, frank dementia is now infrequent, and milder forms of cognitive impairments predominate. Mechanistic insights to the underlying causes of these residual cognitive impairments have been elusive, in part due to the heterogenous etiology of cognitive dysfunction in this population. Here, we sought to categorize longitudinal change in HIV-infected patients based on the performance in specific cognitive domains.

designThis study consisted of 193 participants from the CHARTER cohort with detailed demographic, clinical, and neuropsychological testing data obtained from 2 study visits interspersed by ∼6 months. Cognitive testing assessed executive function, learning and delayed recall, working memory, verbal fluency, speed of information processing, and motor skills. Change scores were calculated for each domain between the 2 study visits. Dimension reduction and clustering was accomplished by principal component analysis of change scores and k-means clustering to identify cognitive domains that group together and groups of subjects with similar patterns of change.

resultsWe identified 4 distinct cognitive change phenotypes that included declines in: (1) verbal fluency, (2) executive function (3) learning and recall, and (4) motor function, with approximately equal numbers of participants in each phenotype.

conclusionsEach of the 4 cognitive change phenotypes identify deficits that imply perturbations in specific neural networks. Future studies will need to validate if cognitive change phenotypes are associated with alterations in associated neural pathways.

Indexed as

PhenotypeAdultAntirheumatic AgentsCognitionCognitive DysfunctionCohort StudiesElectronic Data ProcessingExecutive FunctionFemaleHIV InfectionsHumansLearningMaleMemory, Short-TermMental RecallMiddle AgedAntirheumatic Agents

Identifiers

PMID31107302
PMCPMC6692206

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.